These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 19372860)

  • 1. Stopping HAART temporarily in the absence of virus rebound: exploring new HIV treatment options.
    Lori F; Foli A; Lisziewicz J
    Curr Opin HIV AIDS; 2007 Jan; 2(1):14-20. PubMed ID: 19372860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic immunization in HIV infection.
    Autran B; Kinloch-de Loes S; Katlama C
    Curr Opin HIV AIDS; 2006 Jul; 1(4):323-9. PubMed ID: 19372828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment interruption to boost specific HIV immunity in acute infection.
    Kaufmann DE; Walker BD
    Curr Opin HIV AIDS; 2007 Jan; 2(1):21-5. PubMed ID: 19372861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
    J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virological rebound and its consequences during treatment interruption.
    van Lunzen J; Hoffmann C
    Curr Opin HIV AIDS; 2007 Jan; 2(1):1-5. PubMed ID: 19372858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring clinical trials of therapeutic vaccines in HIV infection: role of treatment interruption.
    Lederman MM; Penn-Nicholson A; Stone SF; Sieg SF; Rodriguez B
    Curr Opin HIV AIDS; 2007 Jan; 2(1):56-61. PubMed ID: 19372866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential impact of early antiretroviral therapy on transmission.
    Pao D; Pillay D; Fisher M
    Curr Opin HIV AIDS; 2009 May; 4(3):215-21. PubMed ID: 19532053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
    Vogel M; Rockstroh JK
    Curr Opin HIV AIDS; 2009 May; 4(3):171-5. PubMed ID: 19532046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission.
    Garcia-Tejedor A; Maiques V; Perales A; Lopez-Aldeguer J
    Acta Obstet Gynecol Scand; 2009; 88(8):882-7. PubMed ID: 19557554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute HIV-1 infection: are we getting there?
    Cellerai C; Little SJ; Loes SK
    Curr Opin HIV AIDS; 2008 Jan; 3(1):67-74. PubMed ID: 19372946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance mutations and the cellular immune response: a valuable synergy for the development of novel immune therapies.
    Chomont N; Trautmann L; Routy JP; Sékaly RP
    Curr Opin HIV AIDS; 2007 Mar; 2(2):116-22. PubMed ID: 19372876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining antiretroviral drugs and immune therapies: an approach to achieve clinical benefit after treatment interruption.
    Lisziewicz J
    Curr Opin HIV AIDS; 2008 Mar; 3(2):104-11. PubMed ID: 19372950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment interruption for convenience, cost cutting and toxicity sparing.
    Nüesch R; Hirschel B
    Curr Opin HIV AIDS; 2007 Jan; 2(1):31-8. PubMed ID: 19372863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral manifestations in human immunodeficiency virus infected children in highly active antiretroviral therapy era.
    dos Santos Pinheiro R; França TT; Ribeiro CM; Leão JC; de Souza IP; Castro GF
    J Oral Pathol Med; 2009 Sep; 38(8):613-22. PubMed ID: 19614862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for managing coinfection with hepatitis B virus and HIV.
    Sherman M
    Cleve Clin J Med; 2009 May; 76 Suppl 3():S30-3. PubMed ID: 19465707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of HIV-infected pregnant women: prevention of virus transmission and adverse effects in mother and child].
    Boer K; Nellen JF; Kreyenbroek ME; Godfried MH
    Ned Tijdschr Geneeskd; 2009; 153():B410. PubMed ID: 19785876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of anger in adherence to highly active antiretroviral treatment in patients infected with HIV.
    Leombruni P; Fassino S; Lavagnino L; Orofino G; Morosini P; Picardi A
    Psychother Psychosom; 2009; 78(4):254-7. PubMed ID: 19468260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between genotypic sensitivity score and treatment outcomes in late stage HIV disease after supervised HAART.
    Castor D; Vlahov D; Hoover DR; Berkman A; Wu YF; Zeller B; Brechtl J; Hammer SM
    J Med Virol; 2009 Aug; 81(8):1323-35. PubMed ID: 19551816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment interruption as a tool to measure changes in immunologic response to HIV-1.
    Kutzler MA; Jacobson JM
    Curr Opin HIV AIDS; 2008 Mar; 3(2):131-5. PubMed ID: 19372954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in the frequencies of torque teno virus subpopulations during HAART treatment in HIV-1-coinfected patients.
    Devalle S; Rua F; Morgado MG; Niel C
    Arch Virol; 2009; 154(8):1285-91. PubMed ID: 19585076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.